UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000058304
Receipt number R000066655
Scientific Title Evaluation of the Effects of Providing Information and Improving the Environment Related to 'NatKali (Sodium-to-Potassium)' on the Urinary Sodium-to-Potassium Ratio and Vegetable Intake
Date of disclosure of the study information 2025/06/27
Last modified on 2025/06/27 18:34:35

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of the Effects of Providing Information and Improving the Environment Related to 'NatKali (Sodium-to-Potassium)' on the Urinary Sodium-to-Potassium Ratio and Vegetable Intake

Acronym

Evaluation of the Effects of Providing Information and Improving the Environment Related to 'NatKali (Sodium-to-Potassium)' on the Urinary Sodium-to-Potassium Ratio and Vegetable Intake

Scientific Title

Evaluation of the Effects of Providing Information and Improving the Environment Related to 'NatKali (Sodium-to-Potassium)' on the Urinary Sodium-to-Potassium Ratio and Vegetable Intake

Scientific Title:Acronym

Evaluation of the Effects of Providing Information and Improving the Environment Related to 'NatKali (Sodium-to-Potassium)' on the Urinary Sodium-to-Potassium Ratio and Vegetable Intake

Region

Japan


Condition

Condition

Healthy

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Assessing the impact of information provision and dietary environment support related to 'NatKali (Sodium-to-Potassium)' on changes in urinary sodium-to-potassium ratio and vegetable consumption

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Urinary sodium-to-potassium ratio, Estimated level of vegetable intake, Estimated amount of vegetable intake

Key secondary outcomes

Blood pressure, Stage of behavioral change, Estimated amount of food intake, Estimated amount of nutrient intake, Salt intake level, Potassium intake level


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -but assessor(s) are blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Food Other

Interventions/Control_1

Providing information about 'NatKali (Sodium-to-Potassium).'

Interventions/Control_2

Providing information about 'NatKali (Sodium-to-Potassium).'
Providing an environment that facilitates vegetable intake (Distribution of vegetable beverages).

Interventions/Control_3

No intervention

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Individuals affiliated with JA Group Kumamoto

Key exclusion criteria

Individuals with chronic kidney disease or a history of such conditions.
Individuals taking medication for diabetes or disorders related to glucose metabolism.
Individuals taking medication for blood pressure treatment.
Individuals with food allergies to the test food.
Individuals receiving dietary guidance regarding potassium from a physician, registered dietitian, or similar professional.
Individuals who are pregnant, breastfeeding, or planning to be during the study period.
Individuals deemed unsuitable as study participants based on the results of a medical interview.
Individuals participating in another human study at the start of this trial.
Any other individuals deemed unsuitable by the principal investigator or the study physician.

Target sample size

390


Research contact person

Name of lead principal investigator

1st name Shigenori
Middle name
Last name Suzuki

Organization

KAGOME CO., LTD.

Division name

Diet & Well-being Research Institute

Zip code

329-2762

Address

17 Nishitomiyama, Nasushiobara-shi, Tochigi

TEL

0287-36-2935

Email

Shigenori_Suzuki@kagome.co.jp


Public contact

Name of contact person

1st name Takuro
Middle name
Last name Inoue

Organization

KAGOME CO., LTD.

Division name

Diet & Well-being Research Institute

Zip code

329-2762

Address

17 Nishitomiyama, Nasushiobara-shi, Tochigi

TEL

0287-36-2935

Homepage URL


Email

Takuro_Inoue@kagome.co.jp


Sponsor or person

Institute

KAGOME CO., LTD.

Institute

Department

Personal name



Funding Source

Organization

KAGOME CO., LTD.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

KAGOME CO., LTD. Research Ethics Review Committee

Address

3-21-1 Nihonbashi Hamacho, Chuo-ku, Tokyo Nihonbashi Hamacho F Tower

Tel

03-5623-8501

Email

IRB@kagome.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 06 Month 27 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2025 Year 06 Month 11 Day

Date of IRB


Anticipated trial start date

2025 Year 06 Month 27 Day

Last follow-up date

2026 Year 06 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 06 Month 27 Day

Last modified on

2025 Year 06 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066655